Authors: WILDEVUUR CRH JANSEN PGM BEZEMER PD KUIK DJ EIJSMAN L BRUINS P DEJONG AP VANHARDEVELT FWJ BIERVLIET JD HASENKAM JM KURE HH KNUDSEN L BELLAICHE L AHLBURG P LOISANCE DY BAUFRETON C LEBESNERAIS P BAJAN G MATTA A VANDYCK M RENOTTE MT PONLOTLOIS A BAELE P MCGOVERN EA MCCARTHY J MCCARTHY A ODONNELL A FOSSE E MOEN O DREGELID E BROCKMEIER V ANDERSON C POMAR JL RANUCCI M CONTI D CIRRI S CONTI E DITTA A VONSEGESSER LK TKEBUCHAVA T WEISS BM TURINA MI SVENNEVIG JL MOHR B VIDEM V KARLSEN H PEDERSEN TH THELIN S HALDEN E HAGMAN L THORNO E AHLVIN E

Citation: Crh. Wildevuur et al., CLINICAL-EVALUATION OF DURAFLO(R)-II HEPARIN TREATED EXTRACORPOREAL-CIRCULATION CIRCUITS (2ND VERSION) - THE EUROPEAN WORKING GROUP ON HEPARIN COATED EXTRACORPOREAL-CIRCULATION CIRCUITS, European journal of cardio-thoracic surgery, 11(4), 1997, pp. 616-623